Osteoporosıs In Chronıc Kıdney Dısease
Open Access
- 15 June 2025
- journal article
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 15 (2) , 125-131
Abstract
Introduction: Bone mineral density disorders are more common in hemodialysis patients than in the general population. However, treatments to increase bone mineral density may increase vascular complications in hemodialysis patients. Bone mineral supplementation treatment regimens that do not increase hemodialysis-related cardiac mortality are necessary. Method: Thirty-three individuals (mean age 72.36±6.55 years; 20 females, 13 males) on hemodialysis for chronic kidney disease were included in the study. Body mass index, calcium, phosphorus, parathormone, bone densitometry results were recorded. In addition, the presence of intravascular calcification in the aorta on radiographs taken within the last 6 months was recorded. The relationships between these parameters were analyzed. Data were analyzed in SPSS. p< 0.05 was taken as the significance criterion. Results: When the dexa scores of 33 individuals with stage 5 CKD on hemodialysis were analyzed, the difference between T scores and PTH values was found to be significant (p=0.020*). As PTH increases, the risk of osteoporosis also increases. Osteopenia and osteoporosis were observed less in individuals with high calcium-phosphorus product. However, the difference between intravascular calcification and calcium-phosphorus product was significant (p=0.004*). The calcium-phosphorus product was significantly higher in the group with extensive aortic calcification compared to the other groups. Calcium-containing agents given with osteoporosis treatment increase cardiovascular mortality in stage-5 chronic kidney disease. Conclusion: Bone mineral density disorders should be treated in hemodialysis patients without increasing vascular calcification. In hemodialysis patients with high risk of cardiovascular disease, osteopenic follow-up can be performed by considering the benefit-harm relationship.Keywords
This publication has 20 references indexed in Scilit:
- Atherosclerosis and Intrarenal Resistance Index in Kidney Transplant RecipientsTransplantation Direct, 2023
- Management of fracture risk in CKD—traditional and novel approachesClinical Kidney Journal, 2022
- Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatmentKidney International, 2020
- A high abdominal aortic calcification score by dual X-ray absorptiometry is associated with cardiovascular events after kidney transplantationNephrology Dialysis Transplantation, 2018
- Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder UseAmerican Journal of Kidney Diseases, 2016
- Safety and efficacy of denosumab in osteoporotic hemodialysed patientsJournal Of Nephrology, 2016
- Bone loss in chronic kidney disease: Quantity or quality?Bone, 2016
- Presence of Abdominal Aortic Calcification Is Significantly Associated With All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2007
- Predictors of aortic and coronary artery calcium on a screening electron beam tomographic scanThe American Journal of Cardiology, 2003
- Electron-Beam Computed Tomography in the Diagnosis of Coronary Artery DiseaseArchives of internal medicine (1960), 2001